Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499
Crossref DOI link: https://doi.org/10.1038/leu.2016.305
Published Online: 2016-10-26
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Smith, M R
Hong, F
Li, H
Gordon, L I
Gascoyne, R D
Paietta, E M
Advani, R H
Forero-Torres, A
Horning, S J
Kahl, B S
Text and Data Mining valid from 2016-10-26
Version of Record valid from 2016-10-26
Article History
First Online: 26 October 2016
Competing interests
: The authors declare no conflict of interest.